US EditionChemo-immunotherapy approach shows potential benefit in patients with advanced HPV-negative head and neck cancer
Summary by HOSPITALS MAGAZINE
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Chemo-immunotherapy approach shows potential benefit in patients with advanced HPV-negative head and neck cancer
Head and neck cancers that are not associated with human papillomavirus (HPV) infection can be treated with a novel treatment strategy including neoadjuvant chemotherapy and immunotherapy with encouraging results, according to a new study Researchers from the University of Chicago Medicine Comprehensive Cancer Center demonstrated the potential of a novel treatment approach including immunotherapy to treat advanced human papillomavirus (HPV)-ne…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
